Is femtosecond LASIK the best option?

Article

A comparative analysis between manual and automated surgery

Initially, flap creation was performed by means of mechanical microkeratomes, with the inconvenience of the generation of flaps that were thinner in the centre than in the periphery, (meniscus-shaped configuration).2 This meniscus of tissue behaved as an additional optical element of the ocular system, inducing new higher order aberrations and modifying the predictability of the second order correction.3

Improvements in mechanical microkeratomes aimed at providing flaps with a more homogeneous thickness profile (planar flap configuration) and of less thickness to leave a thicker stromal residual bed have been developed and introduced in the clinical setting in the last few years. Likewise, femtosecond lasers for LASIK have been also introduced, which are now considered as a significant advancement for corneal laser refractive surgery.4 This type of photodisruptive laser that uses an infrared Nd:Glass laser beam (wavelength 1053 nm) allows the surgeon to program flap creation at a predetermined depth with a high degree of precision.

Our clinical experience

The clinical histories of all patients that had undergone LASIK surgery in our centre since May 2000 were retrospectively reviewed. A total of 13000 surgical procedures had been performed with the mechanical microkeratome Hansatome (Bausch + Lomb, Rochester, New York, USA) and 2000 procedures with the Amadeus microkeratome (Ziemer Ophthalmic Systems, Port, Switzerland). A total of 800 LASIK procedures had been performed with the IntraLase iFS femtosecond technology (Abbott Medical Optics, Santa Ana, California, USA) since January 2011.

According to the clinical guidelines of our centre, a complete preoperative ophthalmological examination had been performed in all cases to evaluate the viability of the corneal surgical procedure. It included uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA), manifest refraction, slit-lamp biomicroscopy, Goldman tonometry, scotopic pupil size measurement, corneal topography, ultrasound pachymetry, biometry, ocular wavefront aberrometry and funduscopy.

The following conditions were considered as exclusion criteria for surgery: estimated stromal residual bed thickness below 250 μm after programming the laser ablation, significant corneal topographic asymmetry, cataract, glaucoma, previous ocular surgery, keratoconus, and any active ocular disease. We only considered for the analysis those cases in which the target postoperative refraction had been emmetropia.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Related Content
© 2025 MJH Life Sciences

All rights reserved.